~~<i id='D5F81981DB'><strike id='D5F81981DB'><tt id='D5F81981DB'><pre id='D5F81981DB'></pre></tt></strike></i>~~

Home» Wikipedia» Wikipedia

Wikipedia

author：fashion 2025-09-06 04:59:01 Page View：322

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Inflation cooled significantly in June, bringing price hikes close to normal levels
Next article： Bright Health sells Medicare Advantage business to Molina

explore

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

Blinken talks high

3:35U.S.SecretaryofStateAntonyBlinkenappearson"GoodMorningAmerica,"onJuly11,2023.ABCNewsU.S.Secretar

23andMe had bad news about my health. I wish a person had delivered it

ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

After half a century, Israel moves to evict squatter from his cave home on the beach

A"welcomehome"blessingmadeofstonesitsatNissimKahlon'shomechiseledoutofthesandstonecliffsoverlookingt